Clinical Study To Evaluate The Efficacy Of Injection Apamarga Ksharjala In The Management Of Keloid

AN OPEN RANDOMISED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF INJECTION APAMARGA KSHARJALA INFILTERATION IN MAMSKANDI WITH SPECIAL REFERENCE TO KELOID

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036958

Enrollment

Registered

2021-09-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L91- Hypertrophic disorders of skin Health Condition 2: L91- Hypertrophic disorders of skin

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having keloid scar 2. Able to understand and give informed consent. 3. Patient age 18-70 year. 4. Recurrent keloid patient who has previous surgery or had undergone any other modality of treatment. 5. Those keloid having area not more than 25 cm2 and elevation 0.6 mm will be included in the study. 6. Mamsakandi over the chest, shoulder and extremities. 7. Mamsakandi in the scar due to traumatic and surgical wounds.

Exclusion criteria

Exclusion criteria: 1. Open wound at or proximity of the lesion. 2. Infected lesion. 3. Those who suffer from immunodeficiency disorder. 4. Atropic scar. 5. Mamsakandi over the Marma Sthan (vital parts) and face. 6. Inflammation over the body. 7. Diabetic patients 8. Mamsakandi in the scars other than traumatic and surgical wounds.

Design outcomes

Primary

Measure	Time frame
WE ARE OBSERVING HERE THE EFFECT OF APAMARG KSHARA JALA INFILTRATION IN THE MAMASAKANDITimepoint: 6 weeks	—

Secondary

Measure	Time frame
Reduce the chances of recurrence in mamskandiTimepoint: 42 days	—

Countries

India

Contacts

Public ContactDR PARIKSHIT SHIRODE

PARUL INSTITUTE OF AYURVED

goldparx@gmail.com9175882746

Outcome results